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ABSTRACT Thefetalresponsetointrauterineinﬂammatorystimuliappearstocontributetotheonsetofpretermlaboraswellas
fetalinjury,especiallyaffectingnewbornsofextremelylowgestationalage.Toinvestigatetheroleofplacentalcolonizationby
speciﬁcgroupsofmicroorganismsinthedevelopmentofinﬂammatoryresponsespresentatbirth,weanalyzed25proteinbio-
markersindrybloodspotsobtainedfrom527newbornsdeliveredbyCaesareansectioninthe23rdto27thgestationweeks.Bac-
teriaweredetectedinplacentasandcharacterizedbyculturetechniques.Oddsratiosforhavingproteinconcentrationsinthe
topquartileforgestationageforindividualandgroupsofmicroorganismswerecalculated.Mixedbacterialvaginosis(BV)or-
ganismswereassociatedwithaproinﬂammatorypatternsimilartothoseofinfectiousfacultativeanaerobes. Prevotellaand
Gardnerellaspecies,anaerobicstreptococci,peptostreptococci,andgenitalmycoplasmaseachappearedtobeassociatedwitha
differentpatternofelevatedbloodlevelsofinﬂammation-relatedproteins. Lactobacilluswasassociatedwithlowoddsofanin-
ﬂammatoryresponse.Thisstudyprovidesevidencethatmicroorganismscolonizingtheplacentaprovokedistinctivenewborn
inﬂammatoryresponsesandthat Lactobacillusmaysuppresstheseresponses.
IMPORTANCE Despiteimprovedintensivecare,pretermandespeciallyextremelylow-gestation-ageneonatescontinuetobeata
considerablyincreasedriskofmorbidity,mortality,anddevelopmentalproblems.Thefetalinﬂammatoryresponseappearsto
contributetotheonsetofpretermlabor,fetalinjury,andcomplications,underlyinglifetimehealthchallengesfacingthesechil-
dren.Thisstudyprovidesevidencethatbacterialcolonizationoftheverypretermplacentaisassociatedwithdistinct
microorganism-speciﬁcinﬂammatoryproteinproﬁlesinthenewbornbloodspecimens.Wealsoprovideevidencethat Lactoba-
cillusreducesinﬂammatoryresponsesinnewborns.Ourdatasupporttheconceptthattargetingofplacentalcolonizationby
speciﬁcdrugsorprobioticsduringearlypregnancyholdspromiseforpreventingnotonlypretermbirthbutalsosubsequentand
long-lasting,inﬂammation-provokedlatesequelae.
Received 3 November 2010 Accepted 14 December 2010 Published 18 January 2011
Citation Fichorova, R. N., A. B. Onderdonk, H. Yamamoto, M. L. Delaney, A. M. DuBois, et al. 2011. Maternal microbe-speciﬁc modulation of inﬂammatory response in extremely
low-gestational-age newborns. mBio 2(1):e00280-10. doi:10.1128/mBio.00280-10.
Editor Peter Gilligan, UNC Health Care System
Copyright © 2011 Fichorova et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported
License, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Address correspondence to Andrew B. Onderdonk, aonderdonk@partners.org.
P
reterm birth, a medical, social, and economic problem, espe-
cially in developed countries, occurs in nearly a half million
pregnancies each year in the United States alone (1, 2). Despite
improved intensive care, preterm and especially extremely low-
gestational-age newborns (ELGANs) continue to be at a signiﬁ-
cantly higher risk of morbidity, mortality, and developmental
problems (1, 2). The systemic fetal inﬂammatory response to in-
trauterine exposures, especially intrauterine infections, is re-
garded as an important contributor to the onset of preterm labor,
fetalinjury,andthemanyandsometimeslifelongsequelaeofearly
organ damage (1–3). In addition to clinically established infec-
tions, noninvasive vaginal microorganisms that ascend into the
uterus also appear to contribute to preterm birth, especially when
criteria are met for the syndrome of disturbed vaginal microﬂora
known as bacterial vaginosis (BV) (3–6). Microbiologically, BV is
deﬁned by decreased vaginal concentrations of Lactobacillus spe-
ciesandincreasednumbersofanaerobicGram-negativerodssuch
asPrevotella,Gardnerellaspecies,andgenitalmycoplasmaspecies,
e.g., Ureaplasma urealyticum and Mycoplasma hominis (7). Al-
though the importance of BV as a risk factor of preterm birth is
well established, routine BV treatment does not appear to reduce
the risk of preterm birth (8–11).
Approximatelyhalfofallplacentasdeliveredbeforethesecond
trimesterand41%ofthosedeliveredbyCaesareansectionharbor
organismsintheirchorions,detectablebyculturetechniques(12).
The high colonization rate decreases with increasing gestational
age.Someofthesemicroorganismsaretypicallypartofthevaginal
microﬂora that might have evolved mechanisms to colonize the
placenta during early pregnancy. We are not aware of studies that
evaluatedtowhatextenttheseorganismsinducesystemicinﬂam-
matoryresponsesinthefetusandnewborn.Inanefforttoexplore
therelationshipsamongspeciﬁcgroupsofmicroorganismsrecov-
ered from the placenta and blood protein indicators of a fetal
inﬂammatoryresponse,weanalyzed25proteinbiomarkersindry
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tion in the 23rd to 27th gestation weeks. The effects of other vari-
ables, e.g., placental histology, pregnancy complications, and
postnatal exposures, on the inﬂammatory responses in the same
study population have been addressed elsewhere (13, 14; T. F.
McElrath, R. N. Fichorova, E. N. Allred, J. L. Hecht, M. A. Ismail,
H. Yuan, and A. Leviton, submitted for publication).
RESULTS
The risks of systemic inﬂammation measured by distinct proﬁles of
inﬂammatory proteins in newborn blood associated with placental
colonization by speciﬁc groups of bacteria are presented as odds ra-
tiosinTables1and2.Thenumberofsamplesthattestedpositivefor
each organism or group of organisms is stated in the bottom row of
each column. The odd ratios indicate the relationship of culture-
positive cases with those whose placentas did not harbor any cultur-
able microorganism rather than with all cases studied.
Of the 527 placentas studied, 313 were culture negative, and
214 were culture positive for one or more microorganisms of the
groups shown in Table 1. Lactobacilli (detected alone or mixed
with other microorganisms in 21 cases or in 9.8% of all culture-
positive placentas) were associated with a prominently low risk of
systemic inﬂammatory reaction in the preterm newborn in con-
trast to the groups of pathogenic microorganisms and organisms
characteristic of bacterial vaginosis (BV), which were all associ-
ated with increased risks of speciﬁc sets of elevated proteins com-
pared to placentas that did not harbor any microorganisms (Ta-
ble 1). The group of BV organisms was most frequently detected,
with Gardnerella vaginalis, Prevotella bivia, anaerobic Streptococ-
cus, and Peptostreptococcus present alone or in mixed culture in
47%or22%ofallculture-positiveplacentas,respectively.TheBV
organisms were associated with a heightened proinﬂammatory
pattern similar to those of the infectious facultative anaerobes
EscherichiacoliandalphaStreptococcus(eachdetectablein28%or
13% of the culture-positive placentas, respectively) and distinct
fromthoseofthevariousgenitalmycoplasmaspecies(collectively
detected in 38% or 18% of the culture-positive placentas, respec-
tively).ThemixedBVmicroorganismsandtheinfectiousfaculta-
tive anaerobes shared an identical pattern of highest odds of ele-
vated levels of interleukin-1 (IL-1), E-selectin, and serum
amyloid A (SAA). In addition, the organisms within these two
groups variably shared odds for elevated levels of IL-6, tumor
necrosis factor alpha (TNF-), TNF receptors, IL-8, intercellular
adhesion molecule 1 (ICAM-1), ICAM-3, C-reactive protein
(CRP),myeloperoxidase(MPO),vascularendothelialgrowthfac-
tor(VEGF),andVEGFreceptor2(VEGF-R2).Intotal,theproin-
ﬂammatory protein proﬁle of the cases of mixed BV culture in-
cluded 9 of the 25 proteins studied and was not duplicated by any
single BV microorganism, suggesting that the proinﬂammatory
effect should be attributable to the cumulative effects of the BV
community rather than that of an individual microbial species.
When BV-associated microorganisms were evaluated separately,
each had its own proﬁle of elevated concentrations of proteins in the
newborn blood samples (Table 1). This analysis included all cases
with a speciﬁc microorganism recovered (including monocultures
and mixed cultures) versus those that did not have any microorgan-
ismrecovered.WhilethepresenceofPrevotellawasassociatedwitha
relativelylowriskofinﬂammatoryresponse,Gardnerellawasmarked
by an increased risk of TNF-, IL-8, ICAM-1, and VEGF-R2, anaer-
obic Streptococcus was associated with a pattern of elevated IL-1,
IL-6, TNF receptor type 1 (TNF-R1), TNF-R2, and E-selectin, and
Peptostreptococcuswascharacterizedbyahighriskofelevatedmacro-
phageinﬂammatoryprotein1(MIP-1),ICAM-3,matrixmetallo-
proteinase 9 (MMP-9), MPO, and VEGF and undetectable insulin
growth factor binding protein 1 (IGF-BP-1).
Cases with cultured genital mycoplasma species (including
Ureaplasma urealyticum and other Mycoplasma spp.) showed a
reproducibleinﬂammatoryproteinpatternthatcloselyresembled
only that of Peptostreptococcus and was dominated by increased
odds of elevated MIP-1, I-TAC (interferon-inducible T cell
alpha-chemoattractant), ICAM-3, MMP-9, MPO, and VEGF and
decreasedoddsofelevatedVEGF-R1andIGF-BP-1.Interestingly,
in contrast to the BV-mixed group and the facultative anaerobes
E. coli and alpha Streptococcus, they were not associated with ele-
vated proinﬂammatory cytokines or the hepatic markers of sys-
temic inﬂammation CRP and SAA.
Skin-associated organisms (Staphylococcus and Propionibacte-
rium species), detectable in 13 to 17% of the culture-positive pla-
centas, were not associated with elevated or reduced concentra-
tions of inﬂammatory proteins in the newborn blood samples.
The levels of IL-6 receptor (IL-6R), monocyte chemotactic
protein1(MCP-1),MCP-4,RANTES(regulateduponactivation,
normal T cell expressed and [presumably] secreted), and MMP-1
in the newborns’ blood samples did not appear to be signiﬁcantly
affected by the presence of any type of cultural bacteria in their
placentas (Table 1).
Because of the distinct low inﬂammatory proﬁle of the
Lactobacillus-positive cases (Table 1) and because most of them
(62%)representedmixedcultures,webrokedownthegroupinto
monoculture and mixed-culture Lactobacillus-positive sub-
groups,andwefurthercontrastedthosetwosubgroupswithcases
where BV organisms were found alone or in combination with
non-BV organisms (Table 2). Again, odds ratios of having top-
quartile protein concentrations were calculated by comparison to
those of cases with no microorganisms recovered.
Although the number of placentas colonized by Lactobacillus
alonewasrelativelysmall(n8),resultinginlackofstatisticalpower,
it was striking that most inﬂammatory proteins, including those as-
sociated with individual or mixed BV microorganisms (IL-1, IL-6,
TNF-R1, TNF-R2, IL-8, MIP-1, ICAM-1, ICAM-3, E-selectin,
MMP-9, CRP, SAA, and VEGF), were completely undetectable in
placentas that harbored Lactobacillus alone (Table 2). In addition,
even when mixed with others (n  13), lactobacilli continued to be
associated with undetectable ICAM-1 and VEGF, and despite the
wide conﬁdence intervals due to the overall low prevalence of Lacto-
bacillus in the ELGAN placentas, the mixed Lactobacillus cultures re-
mained at low odds for all studied proteins.
The opposite was observed in the group positive for BV-
associated species. The cases that were exclusively BV organism
positive(n18)represented38%ofthegroup.Whenthesecases
were separately analyzed, they showed an even higher risk of ele-
vatedproteinconcentrations,includingIL-1,IL-6,TNF-,IL-8,
ICAM-1, ICAM-3, vascular cell adhesion molecule 1 (VCAM-1),
VEGF-R2, and both hepatic markers of systemic inﬂammation,
CRP and SAA (Table 2). In contrast, the group harboring BV
mixedwithothermicroorganisms(n29),ofwhichasigniﬁcant
part (24%) was mixed with Lactobacillus, showed lower odds for
top-quartile concentrations of all cytokines, chemokines, and he-
patic markers of inﬂammation (Table 2, last column), possibly
duetothemodulatoryeffectofLactobacillusinthemixedcultures.
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® mbio.asm.org 3The difference between the groups of Lactobacillus-positive
and -negative cases is illustrated in Fig. 1 by concentration distri-
butions for selected proteins representing the cytokines (IL-6),
chemokines (IL-8), and hepatic inﬂammatory markers (CRP and
SAA).Althoughtheanalysisofrawconcentrationvaluescouldnot
havethenominalstatisticalvalueofthepercentileoddsratioanal-
ysis (Tables 1 and 2) due to the overall low prevalence of Lactoba-
cillus species cultured from the ELGAN placentas, the data dem-
onstrate the contrast between the observed narrow distribution
and lower levels of proteins in the Lactobacillus-positive cases.
DISCUSSION
Our study supports the concept that the placental colonization
withvaginalmicroorganismscaninduceasystemicinﬂammatory
response in the fetus and newborn and that the dominating mo-
lecular features of this response can be dependent on the type of
bacteria. We report molecular patterns distinguishing the groups
of Lactobacillus species, BV-associated species, infectious faculta-
tive anaerobes, genital mycoplasmas, and skin organisms.
In agreement with a widely accepted belief that BV-associated
bacteria are capable of inducing preterm labor, we found that mixed
BV microorganisms are associated with elevated concentrations of
primaryproinﬂammatorycytokines(IL-1,IL-6,andTNF-),capa-
ble of inducing acute phase reactants (CRP and SAA), chemokines
(IL-8), and adhesion molecules (E-selectin, ICAM-1, and ICAM-3).
IL-1,IL-6,andTNF-,asinnateimmunitymediators,playprotec-
tive roles at local sites of bacterial invasion; however, when simulta-
neously and signiﬁcantly elevated in the systemic circulation, these
primary cytokines can induce chemokines, adhesion molecules, and
further leukocyte activation, promoting extravasation and tissue
damageofnoninfectedtissuesasshowninstudiesofthecentralner-
vous system (15). The mixed BV-associated blood protein patterns
were similar to those of infectious facultative anaerobes, e.g., E. coli
and alpha Streptococcus, conﬁrming the pathogenic potential of the
BV microorganisms. Like E. coli and alpha Streptococcus, placental
colonization with mixed BV microorganisms was associated with
high odds of CRP, SAA, and MPO.
TABLE 2 Risk of neonate systemic inﬂammatory response associated with placental colonization by Lactobacillus species alone or mixed with
others in contrast to that by BV-associated species
Protein
Odds ratio (95% conﬁdence intervals)b
Lactobacillus BV-associated spp.c
All (alone
and mixed)
Alone
(monoculture) Mixed
All (alone
and mixed) Alone
Mixed with
any other
microorganism
Cytokines and their receptors
IL-1 0.2 (0, 1.6) — 0.4 (0, 2.8) 2.2 (1.1, 4.2)a 3.4 (1.3, 8.9)a 1.6 (0.7, 3.8)
IL-6 0.4 (0.1, 1.9) — 0.7 (0.2, 3.4) 2.5 (1.3, 4.8)a 3.2 (1.2, 8.5)a 2.1 (0.9, 4.8)
IL-6R 1.6 (0.6, 4.3) 0.6 (0.1, 4.7) 2.5 (0.9, 7.8) 1.9 (0.9, 3.6) 2.0 (0.7, 5.5) 1.8 (0.8, 4.1)
TNF- 0.7 (0.2, 2.3) 0.6 (0.1, 4.7) 0.7 (0.2, 3.3) 2.2 (1.2, 4.3)a 5.0 (1.9, 13)a 1.3 (0.5, 3.1)
TNF-R1 0.6 (0.2, 2.1) — 1.1 (0.3, 4.1) 1.9 (0.98, 3.7) 2.3 (0.9, 6.3) 1.7 (0.7, 3.8)
TNF-R2 0.4 (0.1, 2.0) — 0.8 (0.2, 3.6) 2.2 (1.1, 4.2)a 2.1 (0.8, 5.8) 2.2 (0.98, 5.0)
Chemokines
IL-8 (CXCL8) 0.2 (0, 1.4) — 0.3 (0, 2.4) 1.9 (0.96, 3.6) 2.9 (1.1, 7.6)a 1.4 (0.6, 3.2)
MCP-1 (CCL2) 1.7 (0.7, 4.3) 2.8 (0.7, 12) 1.3 (0.4, 4.2) 1.3 (0.7, 2.6) 1.1 (0.4, 3.1) 1.5 (0.7, 3.3)
MCP-4 (CCL13) 0.9 (0.3, 2.4) — 0.5 (0.1, 2.3) 1.0 (0.5, 2.1) 1.7 (0.7, 4.6) 0.7 (0.3, 1.8)
MIP-1 (CCL4) 1.4 (0.5, 3.9) — 2.7 (0.9, 8.7) 1.9 (0.9, 3.7) 1.7 (0.6, 4.9) 2.0 (0.9, 4.6)
RANTES (CCL5) 1.0 (0.4, 2.9) — 2.1 (0.7, 6.5) 1.3 (0.6, 2.5) 1.3 (0.4, 3.7) 1.3 (0.5, 2.9)
I-TAC (CXCL11) 0.7 (0.2, 2.6) 0.6 (0.1, 5.2) 0.8 (0.2, 3.7) 1.5 (0.7, 3.1) 1.7 (0.6, 4.9) 1.4 (0.6, 3.4)
Adhesion molecules
ICAM-1 (CD54) — — — 2.4 (1.2, 4.7)a 4.7 (1.8, 12)a 1.5 (0.6, 3.7)
ICAM-3 (CD50) 1.4 (0.5, 4.0) — 2.8 (0.9, 8.9) 3.0 (1.6, 5.8)a 3.6 (1.4, 9.5)a 2.7 (1.2, 6.1)a
VCAM-1 (CD106) 1.3 (0.5, 3.5) 0.5 (0.1, 3.9) 2.1 (0.7, 6.5) 1.9 (0.97, 3.6) 2.6 (1.00, 6.9)a 1.5 (0.6, 3.4)
E-selectin (CD62E) 0.3 (0, 1.9) — 0.4 (0.1, 3.3) 2.1 (1.1, 4.3)a 2.5 (0.9, 7.0) 1.9 (0.8, 4.6)
MMPs
MMP-1 0.8 (0.3, 2.6) 2.2 (0.5, 9.3) 0.3 (0, 2.4) 1.0 (0.5, 2.1) 1.0 (0.3, 3.2) 0.9 (0.4, 2.4)
MMP-9 0.8 (0.2, 2.7) — 1.4 (0.4, 5.2) 1.9 (0.98, 3.9) 1.8 (0.6, 5.2) 2.1 (0.9, 4.8)
Other inﬂammation indicators
CRP 0.2 (0, 1.7) — 0.4 (0, 3.0) 2.2 (1.1, 4.2)a 4.6 (1.7, 12)a 1.2 (0.5, 3.1)
SAA 0.3 (0, 1.9) — 0.4 (0.1, 3.3) 2.1 (1.1, 4.3)a 3.2 (1.2, 8.6)a 1.6 (0.6, 3.9)
MPO 1.4 (0.5, 4.0) 0.6 (0.1, 5.3) 2.0 (0.6, 6.7) 2.3 (1.2, 4.5)a 2.2 (0.8, 6.2) 2.4 (1.04, 5.4)a
Growth factors, their receptors, and binding proteins
VEGF — — — 1.8 (0.9, 3.7) 2.0 (0.7, 5.9) 1.7 (0.7, 4.1)
VEGF-R1 (Flt1) 1.0 (0.4, 2.5) 1.2 (0.3, 5.0) 0.9 (0.3, 2.9) 0.7 (0.3, 1.3) 0.8 (0.3, 2.3) 0.6 (0.3, 1.5)
VEGF-R2 (KDR) 0.4 (0, 1.7) — 0.7 (0.1, 3.1) 1.6 (0.8, 3.1) 3.0 (1.1, 7.9)a 1.0 (0.4, 2.5)
IGF-BP-1 0.9 (0.4, 2.5) 2.3 (0.6, 9.5) 0.4 (0.1, 1.9) 0.4 (0.2, 0.9)a 0.7 (0.2, 2.1) 0.3 (0.1, 0.9)a
No. of positive placentas 21 8 13 47 18 29
a Signiﬁcant odds ratio; P  0.05.
b Odds ratios (95% conﬁdence intervals) of blood protein concentrations in the top quartile comparing ELGANs whose placentas harbored a speciﬁc type of bacteria (numbers
stated in the bottom row of each column) with those whose placentas did not harbor any culturable microorganism (n  313). Values in red indicate statistically signiﬁcant
elevations and values in blue indicate signiﬁcantly reduced odds ratios. 0 cells, odds ratio cannot be calculated.
c Including G. vaginalis, P. bivia, anaerobic Streptococcus, and Peptostreptococcus.
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cytokines and acute phase reactants but were associated with an in-
vasive pattern of cytolytic activities mediated by MPO and MIP-1,
whichincreasenitricoxideproduction(16),andextracellularmatrix
degradation enzymes (MMP-9), which are major mediators of in-
ﬂammatorytissuedestruction.MMP-9hasawell-establishedrolein
parturitionandissigniﬁcantlyincreasedintheamnioticﬂuidinpre-
term delivery (17). Mycoplasmas also showed increased levels of
I-TAC, a chemokine for NK and T cells, which may be induced via
Nod-1activationbymycoplasmalipopeptides(18).Nod-1activation
selectivelyinducesimmuneactivationwhile
avoiding upregulation of proinﬂammatory
cytokines(18).Thelackofprimarycytokine
upregulation may also be a result of some
active suppressive properties of these mi-
croorganisms,sincedecreasedexpressionof
IL-1 and IL-8 characterizes mycoplasma-
infected cells (19). Ureaplasma urealyticum
andMycoplasmaspecieswereanalyzedsep-
arately because numerous studies, includ-
ing ours, have implicated them in preterm
birth (20–27). They seemed to contribute
differently to the group pattern of elevated
proteins, with Ureaplasma urealyticum be-
ingthemajorcontributortochemokinere-
sponses, while mixed mycoplasma coloni-
zation seemed needed for increased
MMP-9 levels.
In addition to group-speciﬁc responses,
this study also unveiled unique features of
some individual BV-associated microor-
ganisms.AmongtheBV-associatedspecies,
Prevotella is frequently found in preterm
placentas with high-grade chorionic plate
inﬂammation (28), and it was among the
most prevalent BV-associated microorgan-
ismscolonizingtheELGANplacentainour
study. In vitro work has shown that some
Prevotella strains can exhibit a strong inva-
sive but weak cytokine-inducing capacity,
and this combination of properties may
lead to higher colonization rates and sur-
vival in the host (29). In agreement with
these ﬁndings, our study showed relatively
weak inﬂammatory responses to placental
colonization with Prevotella alone. Gard-
nerella, the most common BV organism
(30, 31), appeared to be the most
inﬂammation-provoking organism and
was associated with the highest odds of ele-
vated TNF-, IL-8, and ICAM-1. Pep-
tostreptococcus, also frequently associated
with high-grade chorionic plate inﬂamma-
tion(28)andlinkedtotissuedestructionin
the gut and oral mucosa (32, 33), showed a
mycoplasma-like inﬂammatory protein
pattern and was associated with the highest
odds of tissue destructive enzymes, e.g.,
MMP-9 and MPO as well as MIP-1 and
ICAM-3. Thus, each of the individual BV-
associated microorganisms contributed uniquely to the pattern of
mixed BV colonization, which demonstrated the biggest variety of
elevated inﬂammatory proteins compared to any other group pat-
tern.ThemixedBVcolonizationconferredariskofnewborninﬂam-
matory response higher than that of any of the individual BV-
associatedmicroorganismsalone,thussupportingtheconceptofBV
as a polymicrobial pathogenic state.
This study suggests that Lactobacillus alone or in mixed placental
colonizationmaysuppressinﬂammatoryresponsesinextremelypre-
term newborns. Our observations add to a growing body of experi-
FIG1 Comparisonofrisksofsystemicinﬂammatoryresponsemeasuredbyselectedproteinsinblood
specimens obtained from newborns with Lactobacillus species versus other organisms detected in their
placentas.Boxplotsrepresentlogarithmicallytransformedinterquartilerangesshowingthenumberof
pg of speciﬁc protein per mg of total protein distributed in four groups by the presence of lactobacilli
and/orothermicroorganisms,asfollows:/(n8),/(n13),/(n193),and/(n
313). The whiskers extend to the upper and lower adjacent values. The upper adjacent value is equal to
the following: the largest data point that is less than or equal to the upper quartile  1.5  (upper
quartile  lower quartile). The lower adjacent value is equal to the following: the smallest data point
that is greater than or equal to the lower quartile  1.5  (upper quartile  lower quartile) (51).
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properties.Lactobacillihavebeenfoundtosuppresspathogenattach-
ment and proliferation in the vaginal epithelium (9). Findings from
in vitro studies with nonvaginal Lactobacillus strains have suggested
that lactobacilli are active modulators of signaling pathways, leading
to a strain-speciﬁc repertoire of cytokine release and immune toler-
ance as well as downregulation of proinﬂammatory signaling (34–
37). Intestinal lactobacilli also inhibit epithelial inﬂammatory re-
sponses to Salmonella lipopolysaccharide (38).
In combination or independently of placental microbial colo-
nization, a number of other prenatal or postnatal factors may
inﬂuence the inﬂammatory protein levels in a newborn’s blood.
Since most of the blood specimens used for the analysis reported
herewereobtainedonthedayofbirth,thebloodproteinconcen-
trations in our analysis were not adjusted for postnatal phenom-
ena and exposures (e.g., nutrition, therapeutic interventions,
postnatal onset of anemia, sepsis, etc.); however, postnatal expo-
sures and clinical outcomes have been analyzed in longitudinal
samples from the same babies collected within the ﬁrst two post-
natal weeks and published elsewhere (13, 14; McElrath et al., sub-
mitted). The wide variance of protein concentrations in ELGANs
with culture-negative placentas (illustrated for some proteins in
Fig. 1) that exceed by logs those found in ELGANs with
Lactobacillus-positive placentas and are sometimes close to those
of other microorganism-positive cases raises the possibilities that
part of the inﬂammation evident in preterm newborns may be
attributabletononculturedmicroorganismsornoninfectiousfac-
tors not addressed in this paper.
Previous publications from our group have shown that the
organismsrecoveredfromtheplacentaareunlikelytobecontam-
inants (28, 39) and that recovery of these organisms provides in-
formation about the risk of preterm delivery (40) as well as struc-
tural and functional consequences of brain damage (23, 41). We
havealsoreportedthatinﬂammationoftheplacentaltissue,often
a consequence of bacteria in the placenta, provides information
abouttheprobabilityofelevatedconcentrationsofinﬂammation-
related proteins in the newborn’s blood (13, 14). Moreover, ele-
vated concentrations of the same inﬂammation-related proteins
provide information about the risk of sonographically deﬁned
brain damage (42). Thus, the present study provides glue to the
existingconstructofclinicalevidencelinkingtheorganismsinthe
placenta to the risk of brain damage attributable to elevated sys-
temic inﬂammatory proteins in the neonate.
Evidence that intrauterine inﬂammatory phenomena contrib-
ute to neonatal disorders (43) prompts us to consider what we
found to be biologically and not just statistically signiﬁcant. Al-
though we have found some evidence for the speciﬁcity of
organism-cytokine relationships, we prefer to emphasize that no
inﬂammatorystimulusaffectsonlyasmallsetofproteins.Indeed,
aninﬂammatorystimulusiscapableofinﬂuencingtheexpression
of more than a thousand genes (44). Thus, what we measured is
likely only the tip of the iceberg. Our neonatal blood specimens
were collected in the intensive care nursery, almost invariably
within 24 h of delivery. Because many inﬂammatory mediators,
e.g., interleukins (45, 46) and TNF- (47), have relatively short
half-lives,wearereluctanttoviewwhatwemeasuredafterbirthto
be limited to intrauterine phenomena. How much of what we
measured should be considered evidence of neonatal rather than
fetal inﬂammation remains to be determined. Nevertheless, our
data clearly demonstrate that maternal microorganisms are asso-
ciated with systemic inﬂammatory patterns detectable after birth.
In conclusion, we provide evidence for microbe-speciﬁc pat-
terns of perinatal inﬂammatory responses. Although in addition
to or independently of placental microorganisms, other prenatal
as well as postnatal factors may contribute to the inﬂammatory
condition and its perpetuation after birth. Our data suggest that
placental colonization by speciﬁc groups of organisms can in-
crease or decrease the risk of a systemic inﬂammatory condition
independently from other factors, and moreover, colonization by
speciﬁc groups of organisms can deﬁne the pattern of circulating
inﬂammatory proteins after birth. Our ﬁndings also suggest that
placenta-derived Lactobacillus diminishes the risk of heightened
inﬂammatory responses in extremely low-gestation-age new-
borns. Although more research is needed to elucidate the molec-
ular mechanisms and health consequences of priming the fetal
and newborn systemic inﬂammatory responses with speciﬁc bac-
terialconstituentsoftheplacenta,ourdatasuggestthatthetarget-
ingofplacentalcolonizationbyspeciﬁcdrugsorprobioticsduring
early pregnancy may hold promise for preventing not only pre-
termbirthbutalsothedevastatingandfar-reachinginﬂammatory
consequences in premature newborns.
MATERIALS AND METHODS
ELGANstudyandnewbornvariables.During2002to2004,theELGAN
studyenrolledmothers(n1,249)andtheirbabies(n1,506)delivered
before 28 weeks of gestation at 14 institutions located in 11 cities of ﬁve
states. The primary goal of the study was to identify parameters and ex-
posuresincreasingtheriskofbraindisordersinELGANs(48).Theenroll-
ment and consent procedures were approved by the human subject re-
search review boards of the individual institutions. This nested study was
limited to 527 of the ELGANs delivered by Caesarean section for whom
blood samples were available for protein measurements closest to birth
(69% within 24 h and all within 72 h of birth) and whose placenta was
biopsied within 1 h after delivery. The demographics of these infants and
their mothers are presented in Table 3.
The gestational age was hierarchically estimated based on the quality
ofavailableinformationandthefollowingsequenceofreliance:(i)known
dates of embryo retrieval, intrauterine insemination, or fetal ultrasound
beforethe14thweek(62%);(ii)fetalultrasoundat14weeks(29%);(iii)
last menstrual period with no fetal ultrasound (7%); and (iv) a record of
the gestation age made in the neonatal intensive care unit log (1%).
Placentas. The placentas were biopsied under sterile conditions as soon
aspossibleafterdelivery(82%within1h)andfurthermicrobiologicallypro-
cessed in an anaerobic chamber as described (39). In brief, a ~1-cm2 tissue
sample was homogenized in 1:10 (wt/vol) phosphate-buffered saline (PBS).
Aliquots of each homogenate were seeded on selective and nonselective me-
dia,asfollows:(i)prereducedbrucellabaseagarcontainingsheepblood(5%),
vitamin K1, and hemin; (ii) tryptic soy agar with sheep blood (5%); (iii)
chocolateagar;and(iv)A-7agar.Establishedcriteriawereusedtoenumerate,
isolate, and identify the different colony types at the Brigham and Women’s
MicrobiologyLaboratory(49).Sincewehavedeterminedthatconstituentsof
the chorion parenchyma prevent the reliable detection of bacterial DNA by
PCR techniques, this study assessed only placental colonization patterns ob-
tained by culture techniques (8).
Blood spot collection and storage. In order to establish the ELGAN
inﬂammatory response associated with placental microbiology while
avoiding as much as possible the potentially independent inﬂammatory
impact of later events related to the clinical management of the ELGANs,
we analyzed the ﬁrst blood sample available closest to birth (postnatal
days1to3).Thestudywaslimitedtospecimensthatremainedafterblood
samples were drawn for clinical care. A blood drop was collected on ﬁlter
paper (Schleicher & Schuell 903), exposed to air at room temperature in
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sealed plastic bags at –70°C.
Elution and measurements of proteins from dried blood spots. All
dried blood specimens were eluted and analyzed in the Laboratory of
GenitalTractBiology(BrighamandWomen’sHospital),whichisaccred-
itedbytheCollegeofAmericanPathologistsforimmunoassaysandcyto-
kine measurement. Disposable 12-mm biopsy punches were used to ex-
cise the blood spot specimens, which were then placed in 0.3 ml PBS with
0.1% Triton X-100 (Sigma-Aldrich, St. Louis, MO) and 0.03% Tween 20
(Fisher, Hampton, NH), vortexed, and placed on a shaker for1ha t4°C.
ThebufferwastransferredalongwiththepapertoaSpinXdual-chamber
ﬁlter tube (Fisher) and spun down at 2,000  g, followed by collection of
the ﬁltered eluted blood specimens. An additional wash of the punch was
performed in 0.1 ml for a ﬁnal elution volume of 0.4 ml.
Protein biomarker levels in the eluted blood specimens were quanti-
ﬁedusingMesoScaleDiscovery(MSD;Gaithersburg,MD)electrochemi-
luminescence (ECL) multiplex immunoassays and Sector Imager 2400,
validatedbycomparisonwithtraditionalenzyme-linkedimmunosorbent
assay(ELISA)(50).Eachassaywasoptimizedforthesimultaneousdetec-
tion of up to 10 proteins within the linearity range of the dry blood spot
elution matrix. The ECL readouts were converted to numbers of pg/mil-
liliters by MSD Workbench software via interpolation from calibrator
curvesstretchingoveratleast4logs.Theinterassaycoefﬁcientofvariation
[CV100standarddeviation(SD)/mean]was10to20%,asassessed
byqualitycontrolsamplealiquotstestedoneachplate.Theaverageoftwo
measurements of each analyte was normalized to the number of mg total
protein,measuredbythePiercebicinchoninicacid(BCA)assay(Thermo
Scientiﬁc, Rockford, IL) and Victor2 reader (PerkinElmer, Boston, MA).
The following 25 protein biomarkers were measured: IL-1, IL-6, IL-
6R, TNF-, TNF-R1, TNF-R2, IL-8 (CXCL8), MCP-1 (CCL2), MCP-4
(CCL13), MIP-1 (macrophage inﬂammatory protein 1) (CCL4),
RANTES (regulated upon activation, normal T cell expressed and [pre-
sumably] secreted) (CCL5), I-TAC (interferon-inducible T cell alpha-
chemoattractant) (CXCL11), ICAM-1 (CD54), ICAM-3 (CD50),
VCAM-1 (CD106), E-SEL (E-selectin) (CD62E), MMP-1, MMP-9, CRP,
SAA, MPO (myeloperoxidase), VEGF (vascular endothelial growth fac-
tor), VEGF-R1, VEGF-R2, and IGF-BP-1.
Data analysis. The generalized null hypothesis evaluated in this study
was that the risk of a blood protein concentration in the highest quartile for
newbornsofaparticulargestationalageisnotassociatedwiththerecoveryof
an organism from their placentas. The focus on the top-quartile concentra-
tionswassupportedbytheconceptthatthehighestconcentrationswouldbe
mostbiologicallysigniﬁcantandbytheobservednonlineardistributionofthe
concentrationsofmostproteinsamongtheELGANchildrenclassiﬁedbythe
presence/absence of each placenta organism.
Becauseproteinconcentrationsvariedwithgestationalageatdelivery,
asdescribedfortheELGANstudyelsewhere(14),wedividedoursamples
into three groups deﬁned by the gestational age category (23 to 24, 25 to
26, and 27 weeks) and deﬁned the highest quartile of each protein among
newbornsineachofthesegestationalagecategories.Ourunitofmeasure-
ment is the odds ratio (and 95% conﬁdence interval) that children whose
placentayieldedanorganismweremorelikelytohaveaproteinmeasure-
mentinthetopquartilethanchildrenwhoseplacentadidnotharborthat
organism (or group of organisms).
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